Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Telefonisches Gesundheitscoaching und telemetrisch unterstutztes Training (TeGeCoach) bei peripherer arterieller verschlusskrankheit (Telephone health coaching and remote exercise monitoring (TeGeCoach) in peripheral arterial occlusive disease -- a randomized controlled trial) [German]
Rezvani F, Heider D, Konig H-H, Herbarth L, Steinisch P, Schuhmann F, Bobinger H, Krack G, Korth T, Thomsen L, Chase DP, Schreiber R, Alscher M-D, Finger B, Harter M, Dirmaier J
Deutsches Arzteblatt International 2024 Apr 19:Epub ahead of print
clinical trial
This trial has not yet been rated.

BACKGROUND: Supervised exercise programs are commonly used to treat intermittent claudication (IC). Home-based exercise programs have been developed to lower barriers to participation. We studied the effects of one such program (TeGeCoach) on self-reported walking ability in patients with IC. METHODS: In a pragmatic, multicenter, randomized and controlled trial (registration number NCT03496948), 1982 patients with symptomatic IC, insured by one of three German statutory health-insurance carriers, received either telephone health coaching with remote exercise monitoring (TeGeCoach; n = 994) or routine care (n = 988). The primary outcome was the change in Walking Impairment Questionnaire (WIQ) scores 12 and 24 months after the start of the intervention (intention-to-treat analysis). The secondary outcomes were health-related quality of life, symptoms of depression or anxiety, health competence, patient activation, alcohol use, and nicotine dependence. RESULTS: There was a significant difference between arms in favor of TeGeCoach in the WIQ (p < 0.0001). Patients in the TeGeCoach arm had WIQ scores that were 6.30 points higher at 12 months (Bonferroni-corrected 95% CI (4.02; 8.59), Cohen's d = 0.26) and 4.55 points higher at 24 months ((2.20; 6.91), d = 0.19). They also fared better in some of the secondary outcomes at 12 months, including physical health-related quality of life and patient activation, with at least small effect sizes (d > 0.20). The average daily step count was no higher in the TeGeCoach group. CONCLUSION: The observed reductions of symptom burden indicate the benefit of home-based exercise programs in the treatment of intermittent claudication. Such programs expand the opportunities for the guideline-oriented treatment of IC. Future studies should address the effect of home-based exercise programs on clinical variables, eg, the 6-minute walk test.

Full text (sometimes free) may be available at these link(s):      help